Fate therapeutics to webcast conference call reporting fourth quarter and full year 2023 financial results

San diego, feb. 15, 2024 (globe newswire) -- fate therapeutics, inc. (the “company” or “fate therapeutics”) (nasdaq: fate), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (ipsc)-derived cellular immunotherapies to patients with cancer and autoimmune disorders, today announced that the company will host a conference call and live audio webcast on monday, february 26, 2024 at 5:00 pm et to report its fourth quarter and full year 2023 financial results and provide a corporate update.
FATE Ratings Summary
FATE Quant Ranking